Drug Shortage Report for TEVA-OMEPRAZOLE
Report ID | 101142 |
Drug Identification Number | 02295407 |
Brand name | TEVA-OMEPRAZOLE |
Common or Proper name | OMEPRAZOLE 10MG TABLETS |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | OMEPRAZOLE |
Strength(s) | 10MG |
Dosage form(s) | TABLET (DELAYED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-12-11 |
Estimated end date | 2020-08-31 |
Actual end date | 2020-08-27 |
Shortage status | Resolved |
Updated date | 2020-08-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-12-12 | English | Compare |
v2 | 2019-12-12 | French | Compare |
v3 | 2020-01-09 | English | Compare |
v4 | 2020-01-09 | French | Compare |
v5 | 2020-02-21 | English | Compare |
v6 | 2020-02-21 | French | Compare |
v7 | 2020-03-05 | English | Compare |
v8 | 2020-03-05 | French | Compare |
v9 | 2020-03-26 | English | Compare |
v10 | 2020-03-26 | French | Compare |
v11 | 2020-04-02 | English | Compare |
v12 | 2020-04-02 | French | Compare |
v13 | 2020-06-04 | English | Compare |
v14 | 2020-06-04 | French | Compare |
v15 | 2020-06-11 | English | Compare |
v16 | 2020-06-11 | French | Compare |
v17 | 2020-08-27 | English | Compare |
v18 | 2020-08-27 | French | Compare |
v19 | 2020-08-28 | English | Compare |
Showing 1 to 19 of 19